| 000 | 01329 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515113116.0 | ||
| 264 | 0 | _c20080429 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a1040-8711 | ||
| 024 | 7 |
_a10.1097/BOR.0b013e3282f5135b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPlenge, Robert M | |
| 245 | 0 | 0 |
_aGenetic variants that predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis: current challenges and future directions. _h[electronic resource] |
| 260 |
_bCurrent opinion in rheumatology _cMar 2008 |
||
| 300 |
_a145-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aBiomarkers, Pharmacological |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xpharmacology |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aCriswell, Lindsey A | |
| 773 | 0 |
_tCurrent opinion in rheumatology _gvol. 20 _gno. 2 _gp. 145-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/BOR.0b013e3282f5135b _zAvailable from publisher's website |
| 999 |
_c17850881 _d17850881 |
||